Clinical Trials
31 trialsMI-CISDIR
Universität Münster
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
QuantumLeap Healthcare Collaborative
COMET
Alliance Foundation Trials, LLC.
APBI RISE
Sanford Health
VEnT
University of Michigan Rogel Cancer Center
MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ
Centre Antoine Lacassagne
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
M.D. Anderson Cancer Center
Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer
M.D. Anderson Cancer Center
Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women
Mayo Clinic
High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer
City of Hope Medical Center
Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)
University of Florida
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
Alliance for Clinical Trials in Oncology
ABCD RT
NRG Oncology
APRESERVE-1
Second Affiliated Hospital, School of Medicine, Zhejiang University
Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors
University of Miami
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
M.D. Anderson Cancer Center
Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants
M.D. Anderson Cancer Center
HISMAR
Hôpital du Valais
TBCRC042
Baylor Breast Care Center
CAN1012 in Pre-Malignant DCIS and LCIS
Providence Health & Services
H-ASSIST
UNC Lineberger Comprehensive Cancer Center
Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
Methodist Health System
BREVIA
University of Aberdeen
EXIST
Thomas Jefferson University
NORDIS
Stanford University
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
University of Pittsburgh
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer
M.D. Anderson Cancer Center
Babytam long
Ente Ospedaliero Ospedali Galliera
VAPEX
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer
M.D. Anderson Cancer Center
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
Mayo Clinic